UNITED EUROPEAN GASTROENTEROLOGY GMBH

Organisation Private Company Austria
VIENNA , Austria

UNITED EUROPEAN GASTROENTEROLOGY GMBH

2
Projects
9
Interests Submitted
882394063
PIC
882394063
Reference

Partner-search announcements

Innovative healthcare interventions for non-communicable diseases

HORIZON-HLTH-2027-02-DISEASE-01-two-stage

Interest expressed: Feb 11, 2026

Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people

HORIZON-HLTH-2026-01-STAYHLTH-02

Interest expressed: Feb 11, 2026

Towards climate resilient, prepared and carbon neutral populations and healthcare systems

HORIZON-HLTH-2026-01-ENVHLTH-04

Interest expressed: Feb 11, 2026

Regulatory science to support translational development of patient-centred health technologies

HORIZON-HLTH-2026-01-IND-03

Interest expressed: Feb 11, 2026

Earlier and more precise palliative care

HORIZON-MISS-2026-02-CANCER-04

Interest expressed: Jan 26, 2026

Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

HORIZON-HLTH-2026-01-DISEASE-09

Interest expressed: Jan 26, 2026

Identifying and addressing low-value care in health and care systems

HORIZON-HLTH-2026-01-CARE-03

Interest expressed: Jan 26, 2026

Advancing knowledge on the impacts of micro- and nanoplastics on human health

HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage

Interest expressed: Aug 07, 2025

Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices

HORIZON-HLTH-2025-03-IND-03-two-stage

Interest expressed: Aug 07, 2025

Projects

HoloSurge

Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers

HORIZON Signed HORIZON-HLTH-2023-TOOL-05

INTERCEPT

Verification and validation of a biomarker panel that identifies individuals at high risk to develop Crohn’s disease allowing INTERCEPTION of full-blown disease development

HORIZON Signed HORIZON-JU-IHI-2024-07-single-stage

Main Collaborations

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (NEW YORK, US)
DIGESTIVE CANCERS EUROPE DICE (BRUSSELS, BE)
PROMETHEUS LABORATORIES INC (SAN DIEGO, US)
SINTEF AS (TRONDHEIM, NO)
METROPOLIA AMMATTIKORKEAKOULU OY (HELSINKI, FI)
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (MUNCHEN, DE)
GLSMED LEARNING HEALTH SA (LISBOA, PT)
STICHTING VU (AMSTERDAM, NL)
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (AMSTERDAM, NL)
CYENS CENTRE OF EXCELLENCE (NICOSIA, CY)

Work Programmes

HORIZON

Additional Information

VAT: ATU70117526
Partner Search: Active